GSK and Vir Biotechnology announce United States government agreements to purchase sotrovimab, a COVID-19 treatment

Approximately two-thirds of these have gone to low- and lower-middle-income countries, including more than 175 million doses delivered to 130 countries through the COVAX Facility.
The vaccine, for which Johnson & Johnson received Emergency Use Authorization from the U.S. Food and Drug Administration in February, is being recognized in the Medical Care category alongside two other COVID-19 vaccines.